Pub Date : 2025-09-30DOI: 10.1016/j.hpr.2025.300797
Shannon Zhang , Nazmul Hasan , John Han , Gianna Kroening , Zeljka Jutric , Ali Afsari , Shirin Attarian , Jennifer Valerin
Cholangiocarcinoma is a rare and aggressive malignancy with a rising incidence in recent years. Known risk factors include cirrhosis, alcohol use, smoking history, family history of bile duct cancer, male gender, and hepatitis B and/or C. The solid-tubulocystic variant of intrahepatic cholangiocarcinoma, previously named cholangioblastic variant, is an even rarer form with only several cases reported in literature to date. Interestingly, this variant is not associated with the same risk factors as typical cholangiocarcinoma, often diagnosed in young, previously healthy females. Given its rarity, diagnosis is often delayed and optimal treatment is unknown, leading to poor prognosis. Here, we discuss the case of an 18-year-old female admitted to our hospital with solid-tubulocystic variant of cholangiocarcinoma, in which molecular analysis confirmed the presence of a characteristic NIPBL-NACC1 gene rearrangement, and our management.
{"title":"A camouflaging mystery: solid-tubulocystic variant of intrahepatic cholangiocarcinoma","authors":"Shannon Zhang , Nazmul Hasan , John Han , Gianna Kroening , Zeljka Jutric , Ali Afsari , Shirin Attarian , Jennifer Valerin","doi":"10.1016/j.hpr.2025.300797","DOIUrl":"10.1016/j.hpr.2025.300797","url":null,"abstract":"<div><div>Cholangiocarcinoma is a rare and aggressive malignancy with a rising incidence in recent years. Known risk factors include cirrhosis, alcohol use, smoking history, family history of bile duct cancer, male gender, and hepatitis B and/or C. The solid-tubulocystic variant of intrahepatic cholangiocarcinoma, previously named cholangioblastic variant, is an even rarer form with only several cases reported in literature to date. Interestingly, this variant is not associated with the same risk factors as typical cholangiocarcinoma, often diagnosed in young, previously healthy females. Given its rarity, diagnosis is often delayed and optimal treatment is unknown, leading to poor prognosis. Here, we discuss the case of an 18-year-old female admitted to our hospital with solid-tubulocystic variant of cholangiocarcinoma, in which molecular analysis confirmed the presence of a characteristic NIPBL-NACC1 gene rearrangement, and our management.</div></div>","PeriodicalId":100612,"journal":{"name":"Human Pathology Reports","volume":"42 ","pages":"Article 300797"},"PeriodicalIF":0.0,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145221938","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-19DOI: 10.1016/j.hpr.2025.300795
Ukuemi Edema , Alexander Chan
B-lymphoblastic leukemia/lymphoma (B-ALL) is a malignant neoplasm of immature B lymphocytes. Occasionally, B-ALL may exhibit morphological and immunophenotypic overlaps with other hematologic malignancies such as B-ALL with isolated myeloperoxidase (MPO) expression which may complicate diagnosis. BRCA1 and BRCA2 are tumor suppressor genes involved in homologous recombination and DNA repair. While germline mutations in these genes are well-established risk factors for breast and ovarian cancers, the association between BRCA1/2 mutations and hematologic malignancies remains underexplored. We present a rare case of B-ALL with isolated MPO expression, discovered incidentally in prophylactically resected ovaries of a patient with a germline BRCA1 mutation, and review the literature exploring this potential association.
{"title":"An incidental B-lymphoblastic leukemia/lymphoma in a prophylactic salpingo-oophorectomy from a patient with germline BRCA1 mutation","authors":"Ukuemi Edema , Alexander Chan","doi":"10.1016/j.hpr.2025.300795","DOIUrl":"10.1016/j.hpr.2025.300795","url":null,"abstract":"<div><div>B-lymphoblastic leukemia/lymphoma (B-ALL) is a malignant neoplasm of immature B lymphocytes. Occasionally, B-ALL may exhibit morphological and immunophenotypic overlaps with other hematologic malignancies such as B-ALL with isolated myeloperoxidase (MPO) expression which may complicate diagnosis. <em>BRCA1</em> and <em>BRCA2</em> are tumor suppressor genes involved in homologous recombination and DNA repair. While germline mutations in these genes are well-established risk factors for breast and ovarian cancers, the association between <em>BRCA1/2</em> mutations and hematologic malignancies remains underexplored. We present a rare case of B-ALL with isolated MPO expression, discovered incidentally in prophylactically resected ovaries of a patient with a germline <em>BRCA1</em> mutation, and review the literature exploring this potential association.</div></div>","PeriodicalId":100612,"journal":{"name":"Human Pathology Reports","volume":"42 ","pages":"Article 300795"},"PeriodicalIF":0.0,"publicationDate":"2025-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145097343","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-15DOI: 10.1016/j.hpr.2025.300796
Daffolyn Rachael Fels Elliott , Kavya Nataraj , Melissa B. Carroll , Rashna Madan , Benjamin C. Powers
Maffucci syndrome is characterized by multiple enchondromas and vascular lesions including spindle cell hemangiomas that typically arise in cutaneous or soft tissue of the extremities. The pathogenesis involves sporadic mutations in IDH1/2 genes that occur early during embryogenesis leading to mosaicism in affected tissues. The prognosis is variable in Maffucci syndrome, and patients have an increased risk of developing malignancies. We present a rare case of multiple spindle cell hemangiomas of the lung in a 41-year-old woman with Maffucci syndrome. She was found to have numerous lung nodules that were slowly progressive on surveillance CT imaging. The radiologic differential diagnosis included diffuse neuroendocrine cell hyperplasia (DIPNECH) with multiple carcinoid tumors and pulmonary metastases. A diagnosis of spindle cell hemangiomas was made following surgical lung wedge biopsy, and PCR detected an IDH1 mutation in codon 132. Annual surveillance whole body and brain MRI showed no new or enlarging lesions one year after her lung biopsy. In conclusion, spindle cell hemangiomas are a rare cause of pulmonary nodules and may arise in the setting of Maffucci syndrome. The lungs are a common site of metastasis from malignancies associated with Maffucci syndrome, but other entities should be kept in the differential diagnosis and may require biopsy for definitive diagnosis.
{"title":"Multiple pulmonary spindle cell hemangiomas with IDH1 mutation in Maffucci syndrome","authors":"Daffolyn Rachael Fels Elliott , Kavya Nataraj , Melissa B. Carroll , Rashna Madan , Benjamin C. Powers","doi":"10.1016/j.hpr.2025.300796","DOIUrl":"10.1016/j.hpr.2025.300796","url":null,"abstract":"<div><div>Maffucci syndrome is characterized by multiple enchondromas and vascular lesions including spindle cell hemangiomas that typically arise in cutaneous or soft tissue of the extremities. The pathogenesis involves sporadic mutations in <em>IDH1/2</em> genes that occur early during embryogenesis leading to mosaicism in affected tissues. The prognosis is variable in Maffucci syndrome, and patients have an increased risk of developing malignancies. We present a rare case of multiple spindle cell hemangiomas of the lung in a 41-year-old woman with Maffucci syndrome. She was found to have numerous lung nodules that were slowly progressive on surveillance CT imaging. The radiologic differential diagnosis included diffuse neuroendocrine cell hyperplasia (DIPNECH) with multiple carcinoid tumors and pulmonary metastases. A diagnosis of spindle cell hemangiomas was made following surgical lung wedge biopsy, and PCR detected an <em>IDH1</em> mutation in codon 132. Annual surveillance whole body and brain MRI showed no new or enlarging lesions one year after her lung biopsy. In conclusion, spindle cell hemangiomas are a rare cause of pulmonary nodules and may arise in the setting of Maffucci syndrome. The lungs are a common site of metastasis from malignancies associated with Maffucci syndrome, but other entities should be kept in the differential diagnosis and may require biopsy for definitive diagnosis.</div></div>","PeriodicalId":100612,"journal":{"name":"Human Pathology Reports","volume":"42 ","pages":"Article 300796"},"PeriodicalIF":0.0,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145097342","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-11DOI: 10.1016/j.hpr.2025.300794
Trevor T Hu , Joyce Pazhyattil , Allison M. Richman , Kathryn Henderson , Darren Groh , Ahmed F. Abdulrahim
Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract, typically driven by mutations in c-KIT or PDGFRA. The CHEK2 gene encodes a checkpoint kinase involved in DNA damage response and has been implicated in hereditary cancer syndromes. However, its role in GIST pathogenesis remains unexplored. We report the case of a 67-year-old male with recurrent GIST who was found to harbor a CHEK2 mutation. The patient initially presented with an abdominal mass, and histopathologic evaluation confirmed a spindle cell neoplasm with strong immunoreactivity for CD117, DOG1, and CD34. Molecular analysis identified a pathogenic CHEK2 mutation, a finding not previously described in GIST. The patient was managed with surgical resection following imatinib therapy, with ongoing surveillance for recurrence. The discovery of a CHEK2 mutation in GIST raises important questions about its potential role in tumorigenesis and therapeutic response. Given the established involvement of CHEK2 in genomic stability and checkpoint regulation, its presence in GIST warrants further investigation. This case highlights the need to explore CHEK2 mutations in larger cohorts to determine their clinical significance and potential impact on treatment strategies. This case represents the first reported association of CHEK2 mutation with GIST, expanding the known genetic landscape of this tumor. Further studies are necessary to elucidate the implications of this mutation in GIST pathophysiology and treatment.
{"title":"Novel association of CHEK2 mutation in gastrointestinal stromal tumor: A case report and literature review","authors":"Trevor T Hu , Joyce Pazhyattil , Allison M. Richman , Kathryn Henderson , Darren Groh , Ahmed F. Abdulrahim","doi":"10.1016/j.hpr.2025.300794","DOIUrl":"10.1016/j.hpr.2025.300794","url":null,"abstract":"<div><div>Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract, typically driven by mutations in<!--> <em>c-KIT</em> <!-->or<!--> <em>PDGFRA</em>. The<!--> <em>CHEK2</em> <!-->gene encodes a checkpoint kinase involved in DNA damage response and has been implicated in hereditary cancer syndromes. However, its role in GIST pathogenesis remains unexplored.<!--> <!-->We report the case of a 67-year-old male with recurrent GIST who was found to harbor a<!--> <em>CHEK2</em> <!-->mutation. The patient initially presented with an abdominal mass, and histopathologic evaluation confirmed a spindle cell neoplasm with strong immunoreactivity for CD117, DOG1, and CD34. Molecular analysis identified a pathogenic<!--> <em>CHEK2</em> <!-->mutation, a finding not previously described in GIST. The patient was managed with surgical resection following imatinib therapy, with ongoing surveillance for recurrence.<!--> <!-->The discovery of a<!--> <em>CHEK2</em> <!-->mutation in GIST raises important questions about its potential role in tumorigenesis and therapeutic response. Given the established involvement of<!--> <em>CHEK2</em> <!-->in genomic stability and checkpoint regulation, its presence in GIST warrants further investigation. This case highlights the need to explore<!--> <em>CHEK2</em> <!-->mutations in larger cohorts to determine their clinical significance and potential impact on treatment strategies. This case represents the first reported association of<!--> <em>CHEK2</em> <!-->mutation with GIST, expanding the known genetic landscape of this tumor. Further studies are necessary to elucidate the implications of this mutation in GIST pathophysiology and treatment.</div></div>","PeriodicalId":100612,"journal":{"name":"Human Pathology Reports","volume":"42 ","pages":"Article 300794"},"PeriodicalIF":0.0,"publicationDate":"2025-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145049902","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-09DOI: 10.1016/j.hpr.2025.300793
Abrar G. Alghamdi , Deema Anaam , Khalid Alwadi
Leiomyosarcoma (LMS) is a malignant tumor of smooth muscle cells. When the tumor originates from a blood vessel, it arises from the smooth muscle cells in the tunica media of the vessel wall. Approximately 15 % of soft tissue sarcomas originate in the retroperitoneum (Kotilingam et al., 2006) [1]. However, LMS of the gonadal vein is extremely rare, with fewer than 15 documented cases. This emphasizes not only its rarity but also the narrow insight into its clinical behaviour and management. Here, we discuss a 42-year-old female patient who presented to our institution with a palpable abdominal mass that had been noticeable for two months. A computed tomography (CT) scan of her abdomen and pelvis revealed a large, irregular right adnexal mass measuring approximately 13 cm, with areas of necrosis and cystic degeneration, resulting in a heterogenous appearance. During surgical resection, the mass appeared to originate from the gonadal vein. Histopathological examination confirmed a diagnosis of leiomyosarcoma. In this article, we review the clinical, radiologic, and histopathologic features of gonadal vein leiomyosarcoma, along with a review of similar case reports.
平滑肌肉瘤(LMS)是一种平滑肌细胞恶性肿瘤。当肿瘤起源于血管时,它起源于血管壁中膜的平滑肌细胞。大约15%的软组织肉瘤起源于腹膜后(Kotilingam et al., 2006)。然而,性腺静脉的LMS极为罕见,文献记载的病例少于15例。这不仅强调了它的罕见性,而且强调了对其临床行为和管理的狭隘见解。在这里,我们讨论一位42岁的女性患者,她以可触及的腹部肿块就诊,该肿块已明显两个月。腹部和骨盆的CT扫描显示右侧附件有一个大的不规则肿块,大小约为13厘米,伴有坏死和囊性变性,导致异质外观。手术切除时,肿块似乎起源于性腺静脉。组织病理学检查证实为平滑肌肉瘤。在这篇文章中,我们回顾了性腺静脉平滑肌肉瘤的临床、放射学和组织病理学特征,并回顾了类似的病例报告。
{"title":"Leiomyosarcoma of the right gonadal vein; A case report with review of literature","authors":"Abrar G. Alghamdi , Deema Anaam , Khalid Alwadi","doi":"10.1016/j.hpr.2025.300793","DOIUrl":"10.1016/j.hpr.2025.300793","url":null,"abstract":"<div><div>Leiomyosarcoma (LMS) is a malignant tumor of smooth muscle cells. When the tumor originates from a blood vessel, it arises from the smooth muscle cells in the tunica media of the vessel wall. Approximately 15 % of soft tissue sarcomas originate in the retroperitoneum (Kotilingam et al., 2006) [<span><span>1</span></span>]. However, LMS of the gonadal vein is extremely rare, with fewer than 15 documented cases. This emphasizes not only its rarity but also the narrow insight into its clinical behaviour and management. Here, we discuss a 42-year-old female patient who presented to our institution with a palpable abdominal mass that had been noticeable for two months. A computed tomography (CT) scan of her abdomen and pelvis revealed a large, irregular right adnexal mass measuring approximately 13 cm, with areas of necrosis and cystic degeneration, resulting in a heterogenous appearance. During surgical resection, the mass appeared to originate from the gonadal vein. Histopathological examination confirmed a diagnosis of leiomyosarcoma. In this article, we review the clinical, radiologic, and histopathologic features of gonadal vein leiomyosarcoma, along with a review of similar case reports.</div></div>","PeriodicalId":100612,"journal":{"name":"Human Pathology Reports","volume":"42 ","pages":"Article 300793"},"PeriodicalIF":0.0,"publicationDate":"2025-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145027751","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-01DOI: 10.1016/j.hpr.2025.300790
Keiichi Kinowaki , Julie S. Deutsch , Marina Baretti , William R. Burns , Kiyoko Oshima
Pilomatrix carcinoma (PC) is a malignant cutaneous tumor characterized by ghost cell keratinization, nuclear positivity for β-catenin, and mutations in catenin beta 1 (CTNNB1) exon 3. We report the first documented case of a primary gallbladder tumor exhibiting a PC-like phenotype with a CTNNB1 exon 3 mutation. The patient was a 74-year-old female who presented with a rapidly enlarging hepatic tumor. The tumor did not respond to preoperative chemotherapy but was removed with surgery. Histopathological examination of resection specimens revealed neoplastic cells forming solid nests of varying sizes, accompanied by ghost cell keratinization and necrosis. Immunohistochemical analysis demonstrated diffusely aberrant nuclear and cytoplasmic β-catenin staining. Molecular testing revealed a CTNNB1 exon 3 mutation. These findings were consistent with a PC-like phenotype. The patient was unresponsive to postoperative chemotherapy and developed pulmonary metastases, leading to death four months after surgery. The tumor is notable for its rapid progression and poor prognosis, highlighting the clinical significance of recognizing this rare histological subtype. To our knowledge, this is the first reported case of a gallbladder neoplasm exhibiting the full spectrum of histopathological and molecular features characteristic of PC, including the CTNNB1 exon 3 mutation.
{"title":"Pilomatrix carcinoma-like gallbladder carcinoma","authors":"Keiichi Kinowaki , Julie S. Deutsch , Marina Baretti , William R. Burns , Kiyoko Oshima","doi":"10.1016/j.hpr.2025.300790","DOIUrl":"10.1016/j.hpr.2025.300790","url":null,"abstract":"<div><div>Pilomatrix carcinoma (PC) is a malignant cutaneous tumor characterized by ghost cell keratinization, nuclear positivity for β-catenin, and mutations in <em>catenin beta 1 (CTNNB1)</em> exon 3. We report the first documented case of a primary gallbladder tumor exhibiting a PC-like phenotype with a <em>CTNNB1</em> exon 3 mutation. The patient was a 74-year-old female who presented with a rapidly enlarging hepatic tumor. The tumor did not respond to preoperative chemotherapy but was removed with surgery. Histopathological examination of resection specimens revealed neoplastic cells forming solid nests of varying sizes, accompanied by ghost cell keratinization and necrosis. Immunohistochemical analysis demonstrated diffusely aberrant nuclear and cytoplasmic β-catenin staining. Molecular testing revealed a <em>CTNNB1</em> exon 3 mutation. These findings were consistent with a PC-like phenotype. The patient was unresponsive to postoperative chemotherapy and developed pulmonary metastases, leading to death four months after surgery. The tumor is notable for its rapid progression and poor prognosis, highlighting the clinical significance of recognizing this rare histological subtype. To our knowledge, this is the first reported case of a gallbladder neoplasm exhibiting the full spectrum of histopathological and molecular features characteristic of PC, including the <em>CTNNB1</em> exon 3 mutation.</div></div>","PeriodicalId":100612,"journal":{"name":"Human Pathology Reports","volume":"41 ","pages":"Article 300790"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144922549","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Kaposi sarcoma is a rare vascular neoplasm associated with Kaposi’s sarcoma-associated Herpesvirus infection. There are four clinical forms of KS, of which Classic and Iatrogenic Kaposi Sarcoma are rare in India. Our patient, a middle-aged woman, presented with generalized lymphadenopathy along with papulonodular skin lesions in the right thigh and gingival mucosa, with an antecedent history of Autoimmune hemolytic anaemia (AIHA) treated with corticosteroids. The histopathology of the lymph node excision revealed a Vaso formative lesion with proliferative spindle cells expressing ERG, CD31, CD34 and Human Herpes virus 8 (HHV8) by immunohistochemistry. The patient was tested seronegative for HIV 1 and 2. Hence, a diagnosis of Kaposi Sarcoma with disseminated mucosal and lymph node metastasis was established. The patient was administered systemic chemotherapy with Liposomal Doxorubicin and is on regular follow-up with no disease progression. We present this case due to its rarity of presentation in an individual of Indian ethnicity preceded by corticosteroid therapy for AIHA for a 6-month duration.
{"title":"Disseminated iatrogenic Kaposi sarcoma in an individual with autoimmune hemolytic anemia from India– A rare case report","authors":"Dhivya Nanjundamoorthi , Suganthi Krishnamurthy , Prabhu Pandurangan","doi":"10.1016/j.hpr.2025.300778","DOIUrl":"10.1016/j.hpr.2025.300778","url":null,"abstract":"<div><div>Kaposi sarcoma is a rare vascular neoplasm associated with Kaposi’s sarcoma-associated Herpesvirus infection. There are four clinical forms of KS, of which Classic and Iatrogenic Kaposi Sarcoma are rare in India. Our patient, a middle-aged woman, presented with generalized lymphadenopathy along with papulonodular skin lesions in the right thigh and gingival mucosa, with an antecedent history of Autoimmune hemolytic anaemia (AIHA) treated with corticosteroids. The histopathology of the lymph node excision revealed a Vaso formative lesion with proliferative spindle cells expressing ERG, CD31, CD34 and Human Herpes virus 8 (HHV8) by immunohistochemistry. The patient was tested seronegative for HIV 1 and 2. Hence, a diagnosis of Kaposi Sarcoma with disseminated mucosal and lymph node metastasis was established. The patient was administered systemic chemotherapy with Liposomal Doxorubicin and is on regular follow-up with no disease progression. We present this case due to its rarity of presentation in an individual of Indian ethnicity preceded by corticosteroid therapy for AIHA for a 6-month duration.</div></div>","PeriodicalId":100612,"journal":{"name":"Human Pathology Reports","volume":"41 ","pages":"Article 300778"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145007659","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-28DOI: 10.1016/j.hpr.2025.300791
Jacob Fiedler , D.O. Caterina Aiello , Tabinda Jawaid , Carinne Anderson , Alla Rudinskaya , Vincent Rella , Jeffrey West , Gunjan Gupta , Paul Fiedler
We report a diagnostically challenging case of a 66-year-old woman with EBV-positive polymorphic B-cell lymphoproliferative disorder (LPD), angioimmunoblastic T-cell lymphoma (AITL), and endometrial adenocarcinoma. Her initial presentation with RS3PE syndrome and a cutaneous eruption mimicking inflammatory breast carcinoma delayed recognition of underlying lymphoid malignancy. Skin biopsy revealed EBV + LPD, and months later she was diagnosed with AITL via lymph node biopsy. All three neoplasms have been linked to elevated vascular endothelial growth factor (VEGF), suggesting a shared pathogenic pathway. This case underscores the importance of considering EBV + LPD as a potential early marker of TFH lymphoma, especially in immunosenescent patients, and raises the possibility of RS3PE as a paraneoplastic harbinger of VEGF-driven disease. Multidisciplinary evaluation was essential to untangle the overlapping clinical and pathological findings.
{"title":"Complex interplay of Epstein-Barr virus-associated lymphoproliferative disorder, angioimmunoblastic T-cell lymphoma, and paraneoplastic syndromes: A case report","authors":"Jacob Fiedler , D.O. Caterina Aiello , Tabinda Jawaid , Carinne Anderson , Alla Rudinskaya , Vincent Rella , Jeffrey West , Gunjan Gupta , Paul Fiedler","doi":"10.1016/j.hpr.2025.300791","DOIUrl":"10.1016/j.hpr.2025.300791","url":null,"abstract":"<div><div>We report a diagnostically challenging case of a 66-year-old woman with EBV-positive polymorphic B-cell lymphoproliferative disorder (LPD), angioimmunoblastic T-cell lymphoma (AITL), and endometrial adenocarcinoma. Her initial presentation with RS3PE syndrome and a cutaneous eruption mimicking inflammatory breast carcinoma delayed recognition of underlying lymphoid malignancy. Skin biopsy revealed EBV + LPD, and months later she was diagnosed with AITL via lymph node biopsy. All three neoplasms have been linked to elevated vascular endothelial growth factor (VEGF), suggesting a shared pathogenic pathway. This case underscores the importance of considering EBV + LPD as a potential early marker of TFH lymphoma, especially in immunosenescent patients, and raises the possibility of RS3PE as a paraneoplastic harbinger of VEGF-driven disease. Multidisciplinary evaluation was essential to untangle the overlapping clinical and pathological findings.</div></div>","PeriodicalId":100612,"journal":{"name":"Human Pathology Reports","volume":"41 ","pages":"Article 300791"},"PeriodicalIF":0.0,"publicationDate":"2025-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144913035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Hepatosplenic T-cell lymphoma (HSTL) is a rare and aggressive mature T-cell lymphoma characterized by hepatosplenic involvement. It usually occurs de novo in adolescents and young adults (AYA) and has been most commonly reported in the setting of immunosuppression. Most cases present with proliferation of cytotoxic T-cells of TCRγδ type with a unique gene mutation profile. Due to rarity of this disease, there is no standard of care treatment, and outcomes are usually poor in the absence of stem cell transplant. In this case, we report an unusual presentation of HSTL of TCRαβ type in an elderly patient status post treatment of an indolent B-cell lymphoma.
{"title":"Hepatosplenic T-cell lymphoma, αβ type, presenting in an elderly patient status post indolent B-cell lymphoma treatment: report of a case and review of the literature","authors":"Rodolfo Garza-Morales , Isabela Wen-Chi Chang , Allison Rosenthal , Jiehao Zhou","doi":"10.1016/j.hpr.2025.300789","DOIUrl":"10.1016/j.hpr.2025.300789","url":null,"abstract":"<div><div>Hepatosplenic T-cell lymphoma (HSTL) is a rare and aggressive mature T-cell lymphoma characterized by hepatosplenic involvement. It usually occurs <em>de novo</em> in adolescents and young adults (AYA) and has been most commonly reported in the setting of immunosuppression. Most cases present with proliferation of cytotoxic T-cells of TCRγδ type with a unique gene mutation profile. Due to rarity of this disease, there is no standard of care treatment, and outcomes are usually poor in the absence of stem cell transplant. In this case, we report an unusual presentation of HSTL of TCRαβ type in an elderly patient status post treatment of an indolent B-cell lymphoma.</div></div>","PeriodicalId":100612,"journal":{"name":"Human Pathology Reports","volume":"41 ","pages":"Article 300789"},"PeriodicalIF":0.0,"publicationDate":"2025-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144885884","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}